Abiraterone
The serum concentration of Cariprazine can be increased when it is combined with Abiraterone.
Acetyl Sulfisoxazole
The metabolism of Cariprazine can be decreased when combined with Acetyl sulfisoxazole.
Almotriptan
The risk or severity of adverse effects can be increased when Almotriptan is combined with Cariprazine.
Advertisement
Amantadine
The therapeutic efficacy of Amantadine can be decreased when used in combination with Cariprazine.
Amiodarone
The metabolism of Cariprazine can be decreased when combined with Amiodarone.
Amisulpride
Cariprazine may increase the antipsychotic activities of Amisulpride.
Advertisement
Amitriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Cariprazine.
Amoxapine
The risk or severity of adverse effects can be increased when Amoxapine is combined with Cariprazine.
Amphetamine
The metabolism of Cariprazine can be decreased when combined with Amphetamine.
Advertisement
Apalutamide
The serum concentration of Cariprazine can be decreased when it is combined with Apalutamide.
Apomorphine
The therapeutic efficacy of Apomorphine can be decreased when used in combination with Cariprazine.
Aprepitant
The serum concentration of Cariprazine can be increased when it is combined with Aprepitant.
Artemether
The metabolism of Cariprazine can be decreased when combined with Artemether.
Atazanavir
The metabolism of Cariprazine can be decreased when combined with Atazanavir.
Atomoxetine
The metabolism of Cariprazine can be decreased when combined with Atomoxetine.
Benzphetamine
Cariprazine may decrease the stimulatory activities of Benzphetamine.
Benzylpenicilloyl polylysine
Cariprazine may decrease effectiveness of Benzylpenicilloyl Polylysine as a diagnostic agent.
BETAHISTINE
The therapeutic efficacy of Betahistine can be decreased when used in combination with Cariprazine.
Betaxolol
The metabolism of Cariprazine can be decreased when combined with Betaxolol.
Boceprevir
The metabolism of Cariprazine can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Cariprazine can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Cariprazine can be decreased when it is combined with Bosentan.
Bosentan Anhydrous
The serum concentration of Cariprazine can be decreased when it is combined with Bosentan.
Bromocriptine
Bromocriptine may increase the vasoconstricting activities of Cariprazine.
Bupropion
The metabolism of Cariprazine can be decreased when combined with Bupropion.
Buspirone
The risk or severity of adverse effects can be increased when Buspirone is combined with Cariprazine.
Cabergoline
Cabergoline may increase the vasoconstricting activities of Cariprazine.
Carbamazepine
The metabolism of Cariprazine can be increased when combined with Carbamazepine.
Celecoxib
The metabolism of Cariprazine can be decreased when combined with Celecoxib.
Ceritinib
The serum concentration of Cariprazine can be increased when it is combined with Ceritinib.
Chloroquine
The metabolism of Cariprazine can be decreased when combined with Chloroquine.
Chlorpromazine
The metabolism of Cariprazine can be decreased when combined with Chlorpromazine.
Cholecalciferol
The metabolism of Cariprazine can be decreased when combined with Cholecalciferol.
Cimetidine
The metabolism of Cariprazine can be decreased when combined with Cimetidine.
Cinacalcet
The metabolism of Cariprazine can be decreased when combined with Cinacalcet.
Citalopram
The metabolism of Cariprazine can be decreased when combined with Citalopram.
Clarithromycin
The metabolism of Cariprazine can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Cariprazine can be decreased when combined with Clemastine.
Clobazam
The metabolism of Cariprazine can be decreased when combined with Clobazam.
Clomipramine
The metabolism of Cariprazine can be decreased when combined with Clomipramine.
Clotrimazole
The metabolism of Cariprazine can be decreased when combined with Clotrimazole.
Clozapine
The metabolism of Cariprazine can be decreased when combined with Clozapine.
Cobicistat
The serum concentration of Cariprazine can be increased when it is combined with Cobicistat.
Cocaine
The metabolism of Cariprazine can be decreased when combined with Cocaine.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Cariprazine.
Crizotinib
The metabolism of Cariprazine can be decreased when combined with Crizotinib.
Curcumin
The metabolism of Cariprazine can be decreased when combined with Curcumin.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Cariprazine.
Cyclosporine
The metabolism of Cariprazine can be decreased when combined with Cyclosporine.
Dabrafenib
The serum concentration of Cariprazine can be decreased when it is combined with Dabrafenib.
Darifenacin
The metabolism of Cariprazine can be decreased when combined with Darifenacin.
Darunavir
The serum concentration of Cariprazine can be increased when it is combined with Darunavir.
Dasatinib
The serum concentration of Cariprazine can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Cariprazine can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Cariprazine can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Cariprazine can be decreased when combined with Delavirdine.
Desipramine
The metabolism of Cariprazine can be decreased when combined with Desipramine.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Desvenlafaxine is combined with Cariprazine.
Deutetrabenazine
The risk or severity of adverse effects can be increased when Cariprazine is combined with Deutetrabenazine.
Dextroamphetamine
Cariprazine may decrease the stimulatory activities of Dextroamphetamine.
Dextromethorphan
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Cariprazine.
Diethylpropion
Cariprazine may decrease the stimulatory activities of Diethylpropion.
Dihydroergotamine
Dihydroergotamine may increase the vasoconstricting activities of Cariprazine.
Diltiazem
The metabolism of Cariprazine can be decreased when combined with Diltiazem.
Diphenhydramine
The metabolism of Cariprazine can be decreased when combined with Diphenhydramine.
Dothiepin
The metabolism of Cariprazine can be decreased when combined with Dosulepin.
Doxepin
The risk or severity of adverse effects can be increased when Doxepin is combined with Cariprazine.
Doxycycline
The metabolism of Cariprazine can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Cariprazine can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Cariprazine can be decreased when combined with Dronedarone.
Droxidopa
Cariprazine may increase the hypertensive activities of Droxidopa.
Duloxetine
The metabolism of Cariprazine can be decreased when combined with Duloxetine.
Eletriptan
The risk or severity of adverse effects can be increased when Eletriptan is combined with Cariprazine.
Eliglustat
The metabolism of Cariprazine can be decreased when combined with Eliglustat.
Enzalutamide
The serum concentration of Cariprazine can be decreased when it is combined with Enzalutamide.
ergoloid mesylates, USP
Ergoloid mesylate may increase the vasoconstricting activities of Cariprazine.
Ergonovine
Ergonovine may increase the vasoconstricting activities of Cariprazine.
Ergotamine
Ergotamine may increase the vasoconstricting activities of Cariprazine.
Erythromycin
The metabolism of Cariprazine can be decreased when combined with Erythromycin.
Escitalopram
The risk or severity of adverse effects can be increased when Escitalopram is combined with Cariprazine.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Cariprazine.
Fluconazole
The metabolism of Cariprazine can be decreased when combined with Fluconazole.
Fluoxetine
The metabolism of Cariprazine can be decreased when combined with Fluoxetine.
Fluvoxamine
The metabolism of Cariprazine can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Cariprazine can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Cariprazine can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Cariprazine can be increased when combined with Fosphenytoin.
Frovatriptan
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Cariprazine.
Furazolidone
The metabolism of Cariprazine can be decreased when combined with Furazolidone.
Fusidate
The serum concentration of Cariprazine can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Cariprazine can be increased when it is combined with Fusidic Acid.
Haloperidol
The metabolism of Cariprazine can be decreased when combined with Haloperidol.
Hyaluronidase
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Cariprazine.
Hyaluronidase, Ovine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Cariprazine.
Hypoxis hemerocallidea root extract
The serum concentration of Cariprazine can be decreased when it is combined with St. John's Wort.
Idelalisib
The metabolism of Cariprazine can be decreased when combined with Idelalisib.
Imatinib
The metabolism of Cariprazine can be decreased when combined with Imatinib.
Imipramine
The metabolism of Cariprazine can be decreased when combined with Imipramine.
Indinavir
The metabolism of Cariprazine can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Cariprazine can be decreased when combined with Indinavir.
Iproniazid
The metabolism of Cariprazine can be decreased when combined with Iproniazid.
Isavuconazole
The serum concentration of Cariprazine can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Cariprazine can be decreased when combined with Isavuconazonium.
Isocarboxazid
The metabolism of Cariprazine can be decreased when combined with Isocarboxazid.
Isoniazid
The metabolism of Cariprazine can be decreased when combined with Isoniazid.
Isradipine
The metabolism of Cariprazine can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Cariprazine can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Cariprazine can be increased when it is combined with Ivacaftor.
Ketoconazole
The metabolism of Cariprazine can be decreased when combined with Ketoconazole.
Lamotrigine
The risk or severity of adverse effects can be increased when Lamotrigine is combined with Cariprazine.
Levodopa
The therapeutic efficacy of Levodopa can be decreased when used in combination with Cariprazine.
Levomilnacipran
The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Cariprazine.
Linezolid
The risk or severity of adverse effects can be increased when Linezolid is combined with Cariprazine.
Lisdexamfetamine
Cariprazine may decrease the stimulatory activities of Lisdexamfetamine.
Lisdexamfetamine Dimesylate
Cariprazine may decrease the stimulatory activities of Lisdexamfetamine.
Lithium
Lithium may increase the neurotoxic activities of Cariprazine.
Lithium Cation
Lithium may increase the neurotoxic activities of Cariprazine.
Lopinavir
The metabolism of Cariprazine can be decreased when combined with Lopinavir.
Lorcaserin
The metabolism of Cariprazine can be decreased when combined with Lorcaserin.
Lovastatin
The metabolism of Cariprazine can be decreased when combined with Lovastatin.
Luliconazole
The serum concentration of Cariprazine can be increased when it is combined with Luliconazole.
Lumacaftor
The metabolism of Cariprazine can be increased when combined with Lumacaftor.
Lumefantrine
The metabolism of Cariprazine can be decreased when combined with Lumefantrine.
Manidipine
The metabolism of Cariprazine can be decreased when combined with Manidipine.
Maprotiline
The risk or severity of adverse effects can be increased when Maprotiline is combined with Cariprazine.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Cariprazine.
Mephentermine
Cariprazine may decrease the stimulatory activities of Mephentermine.
Mequitazine
Cariprazine may increase the arrhythmogenic activities of Mequitazine.
Methadone
The metabolism of Cariprazine can be decreased when combined with Methadone.
Methamphetamine
Cariprazine may decrease the stimulatory activities of Methamphetamine.
Methotrimeprazine
The metabolism of Cariprazine can be decreased when combined with Methotrimeprazine.
Methylene blue
The metabolism of Cariprazine can be decreased when combined with Methylene blue.
Methylergonovine
Methylergometrine may increase the vasoconstricting activities of Cariprazine.
Methylphenidate
The risk or severity of adverse effects can be increased when Cariprazine is combined with Methylphenidate.
Metoclopramide
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Cariprazine.
Metoprolol
The metabolism of Cariprazine can be decreased when combined with Metoprolol.
Metyrosine
The risk or severity of adverse effects can be increased when Metyrosine is combined with Cariprazine.
Midostaurin
The metabolism of Cariprazine can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Cariprazine can be increased when it is combined with Mifepristone.
Milnacipran
The risk or severity of adverse effects can be increased when Milnacipran is combined with Cariprazine.
Minaprine
The metabolism of Cariprazine can be decreased when combined with Minaprine.
Mirabegron
The metabolism of Cariprazine can be decreased when combined with Mirabegron.
Mirtazapine
The risk or severity of adverse effects can be increased when Mirtazapine is combined with Cariprazine.
Mitotane
The serum concentration of Cariprazine can be decreased when it is combined with Mitotane.
Moclobemide
The metabolism of Cariprazine can be decreased when combined with Moclobemide.
Naratriptan
The risk or severity of adverse effects can be increased when Naratriptan is combined with Cariprazine.
Nefazodone
The metabolism of Cariprazine can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Cariprazine can be decreased when combined with Nelfinavir.
Netupitant
The serum concentration of Cariprazine can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Cariprazine can be increased when combined with Nevirapine.
Nialamide
The metabolism of Cariprazine can be decreased when combined with Nialamide.
Nicardipine
The metabolism of Cariprazine can be decreased when combined with Nicardipine.
Nilotinib
The metabolism of Cariprazine can be decreased when combined with Nilotinib.
Nortriptyline
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Cariprazine.
Olaparib
The metabolism of Cariprazine can be decreased when combined with Olaparib.
Osimertinib
The serum concentration of Cariprazine can be increased when it is combined with Osimertinib.
p-Hydroxyamphetamine
Cariprazine may decrease the stimulatory activities of Hydroxyamphetamine.
Palbociclib
The serum concentration of Cariprazine can be increased when it is combined with Palbociclib.
Panobinostat
The serum concentration of Cariprazine can be increased when it is combined with Panobinostat.
Pargyline
The metabolism of Cariprazine can be decreased when combined with Pargyline.
Paroxetine
The metabolism of Cariprazine can be decreased when combined with Paroxetine.
Peginterferon Alfa-2b
The serum concentration of Cariprazine can be decreased when it is combined with Peginterferon alfa-2b.
Pentobarbital
The metabolism of Cariprazine can be increased when combined with Pentobarbital.
Phenelzine
The metabolism of Cariprazine can be decreased when combined with Phenelzine.
Phenobarbital
The metabolism of Cariprazine can be increased when combined with Phenobarbital.
Phentermine
Cariprazine may decrease the stimulatory activities of Phentermine.
PHENTERMINE RESIN
Cariprazine may decrease the stimulatory activities of Phentermine.
Phenytoin
The metabolism of Cariprazine can be increased when combined with Phenytoin.
Piribedil
The therapeutic efficacy of Piribedil can be decreased when used in combination with Cariprazine.
Posaconazole
The metabolism of Cariprazine can be decreased when combined with Posaconazole.
Pramipexole
The therapeutic efficacy of Pramipexole can be decreased when used in combination with Cariprazine.
Primidone
The metabolism of Cariprazine can be increased when combined with Primidone.
Procaine
The metabolism of Cariprazine can be decreased when combined with Procaine.
Procarbazine
The metabolism of Cariprazine can be decreased when combined with Procarbazine.
Promazine
The metabolism of Cariprazine can be decreased when combined with Promazine.
Promethazine
The risk or severity of adverse effects can be increased when Promethazine is combined with Cariprazine.
Protriptyline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Cariprazine.
Pseudoephedrine
Cariprazine may decrease the stimulatory activities of Pseudoephedrine.
Quinagolide
The therapeutic efficacy of Quinagolide can be decreased when used in combination with Cariprazine.
Quinidine
The metabolism of Cariprazine can be decreased when combined with Quinidine.
Quinine
The metabolism of Cariprazine can be decreased when combined with Quinine.
Ranolazine
The metabolism of Cariprazine can be decreased when combined with Ranolazine.
Rasagiline
The metabolism of Cariprazine can be decreased when combined with Rasagiline.
Rifabutin
The metabolism of Cariprazine can be increased when combined with Rifabutin.
Rifampin
The metabolism of Cariprazine can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Cariprazine can be increased when combined with Rifapentine.
Ritonavir
The metabolism of Cariprazine can be decreased when combined with Ritonavir.
Rizatriptan
The risk or severity of adverse effects can be increased when Rizatriptan is combined with Cariprazine.
Rolapitant
The metabolism of Cariprazine can be decreased when combined with Rolapitant.
Ropinirole
The therapeutic efficacy of Ropinirole can be decreased when used in combination with Cariprazine.
Rotigotine
The therapeutic efficacy of Rotigotine can be decreased when used in combination with Cariprazine.
Rucaparib
The metabolism of Cariprazine can be decreased when combined with Rucaparib.
Saquinavir
The metabolism of Cariprazine can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Cariprazine can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Cariprazine can be decreased when used in combination with Sarilumab.
Selegiline
The metabolism of Cariprazine can be decreased when combined with Selegiline.
Sertraline
The metabolism of Cariprazine can be decreased when combined with Sertraline.
Sildenafil
The metabolism of Cariprazine can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Cariprazine can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Cariprazine can be increased when it is combined with Simeprevir.
ST. JOHN'S WORT EXTRACT
The serum concentration of Cariprazine can be decreased when it is combined with St. John's Wort.
Sulfisoxazole
The metabolism of Cariprazine can be decreased when combined with Sulfisoxazole.
Sulpiride
Cariprazine may increase the antipsychotic activities of Sulpiride.
Sumatriptan
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Cariprazine.
Sumatriptan Succinate
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Cariprazine.
Tapentadol
The risk or severity of adverse effects can be increased when Tapentadol is combined with Cariprazine.
Tedizolid
The risk or severity of adverse effects can be increased when Tedizolid Phosphate is combined with Cariprazine.
Tedizolid Phosphate
The risk or severity of adverse effects can be increased when Tedizolid Phosphate is combined with Cariprazine.
Telaprevir
The metabolism of Cariprazine can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Cariprazine can be decreased when combined with Telithromycin.
Terbinafine
The metabolism of Cariprazine can be decreased when combined with Terbinafine.
Tetrabenazine
The risk or severity of adverse effects can be increased when Tetrabenazine is combined with Cariprazine.
Thioridazine
The metabolism of Cariprazine can be decreased when combined with Thioridazine.
Ticlopidine
The metabolism of Cariprazine can be decreased when combined with Ticlopidine.
Tipranavir
The metabolism of Cariprazine can be decreased when combined with Tipranavir.
Tocilizumab
The serum concentration of Cariprazine can be decreased when it is combined with Tocilizumab.
Toloxatone
The metabolism of Cariprazine can be decreased when combined with Toloxatone.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Cariprazine.
Tranylcypromine
The metabolism of Cariprazine can be decreased when combined with Tranylcypromine.
Trazodone
The risk or severity of adverse effects can be increased when Trazodone is combined with Cariprazine.
Trimipramine
The risk or severity of adverse effects can be increased when Trimipramine is combined with Cariprazine.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Cariprazine.
Venlafaxine
The metabolism of Cariprazine can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Cariprazine can be decreased when combined with Verapamil.
Vilazodone
The risk or severity of adverse effects can be increased when Vilazodone is combined with Cariprazine.
Voriconazole
The metabolism of Cariprazine can be decreased when combined with Voriconazole.
Vortioxetine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Cariprazine.
Ziprasidone
The metabolism of Cariprazine can be decreased when combined with Ziprasidone.
Zolmitriptan
The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Cariprazine.
